The president requested a budget of $234 million more than the approved budget. The FDA’s total budget, which includes user fees, is $3.8 billion. The House is set to vote on the final report this week.
Related Articles on the FDA:
FDA Opens Comment Period on Device Reclassification Process
10 Recent FDA Drug and Medical Device Decisions
FDA Approves Carestream’s Vue Motion Medical Image Viewer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
